14Jul
Japan Tightens Foreign Direct Investment Regulations on Life Science Companies - Prior notification requirements under the Japanese regulations were expanded to cover investments in life science companies.
On June 15, 2020, the Japanese government implemented new regulations that designate the manufacture of pharmaceuticals for infectious diseases and the manufacture of highly-controlled medical devices (medical devices that are classified as Class III or Class IV in Japan, such as a heart–lung machines and ventilators) as both "Designated Businesses" and "Core Businesses" under the Foreign Exchange and Foreign Trade Act of Japan ("FEFTA"). The new regulations were adopted in light of the COVID-19...
By:
Jones Day
Related
GOVERNMENT CONTRACTS LAW - Late Is Late—Even on the GSA Schedule - In a recent blog, we discuss...
Read More >
The first half of 2019 saw several decisions from the Delaware courts that will affect M&A dealmakin...
Read More >
Despite holding office for less than a year, Colorado Governor Jared Polis has signed and advocated ...
Read More >
For my 3rd anniversary special episode, I am joined once again by Howard Schweitzer to talk all thin...
Read More >
Activism affects virtually everyone now—even those who may never have to deal with an activist - I...
Read More >
On July 2, 2019, New Jersey Governor Phil Murphy signed into law the Jake Honig Compassionate Use Me...
Read More >